Maxwell Fotoniks LLC is the Russian innovative company invested by the Maxwell Biotekh venture fund created with participation of the capital of JSC Russian Venture Capital Company conducts development and plans production and an output to the domestic market of essentially new medical laser systems for surgery of soft and solid fabrics.
The main scope of the equipment "Maxwell Fotoniks" – stomatology, perspective is also its use at surgical interventions in obstetrics and gynecology, otorhinolaryngology, a proktologiya and other fields of medicine. A co-investor of Maxwell Fotoniks company is also the Fund of sowing investments RVC.
"Maxwell Fotoniks", entering in "Maxwell of Biothose Groups", conducts development and production of the latest equipment in close partnership with the international companies Dental Photonics and Laser Abrasive Technologies, developers of innovations in the field of medical laser technologies. Their compactness, multifunctionality, ergonomics and also rather low cost will become main advantages of the new laser systems.
History
On July 4, 2011 the first ceremony of assignment of status of the resident of the innovation center "Skolkovo" was held. The biotechnology company "Maxwell Fotoniks" joined a cluster of biomedical technologies.
The managing partner of Maxwell Biotekh group Dmitry Popov, is sure that "the equipment developed within the Maxwell Fotoniks project and using the best technological solutions for production of the surgical laser systems will take considerable positions in the market of laser devices of medical appointment". "We are very glad that the next project of group received positive assessment of experts of Skolkovo Foundation and became the resident of the innovation center".
"Providing Maxwell Fotoniks of resident status Skolkovo is one more demonstration of the fact that one of elements of "the innovation elevator" - a linking of RVC Skolkovo – already functions uninterruptedly. It is necessary to notice that preferences which are provided to residents Skolkovo significantly optimize business plans of the companies, and it very positively influences both project deadlines of venture funds, and growth of capitalization of their portfolio companies. In view of considerable experience of partners "Maxwell Biotekh of Groups" and competitive advantages which are provided by Skolkovo we are sure of serious success of Maxwell Biotekh portfolio company and Fund of sowing investments of RVC", - the director of the department of investments and examination of JSC RVC Jan Vladimirovich Ryazantsev commented on an event.